Our non-invasive blood biomarkers can benefit studies in osteoarthritis, and for safety studies where structural changes to the joint are necessary to monitor. Read more about how disease activity can be monitored with the aid of Nordic Bioscience biomarkers, or understand to a deeper extent how the pharmacodynamic modulation occurs. 

More about our biomarkers for Osteoarthritis

Find publications

Our blood-based tissue-derived biomarkers can quantify changes in joint tissues (e.g. bone, cartilage and connective tissues), and they can be used for monitoring pharmacodynamics, prognosis and prediction of efficacy in Rheumatoid Arthritis.

More about our biomarkers for Rheumatoid Arthritis

Find publications

Axial spondyloarthritis (axSpA) is a chronic inflammatory disease that mainly affects the axial skeleton including the spine and the sacroiliac joints. ECM remodelling occurring in the affected tissues, can be quantified by tissue-specific biomarkers. This enables the monitoring of disease activity, providing valuable insights into the disease mechanisms and complexity in axSpA.

More about our biomarkers for Axial Spondyloarthritis (axSpA)

Find publications

Systemic skin diseases with local manifestations are characterized by excessive tissue remodeling and immune cell activity. Tissue-specific biomarkers, quantifying and monitoring immune cell activity, are key advantages when we want to understand the disease mechanisms and complexity in systemic sclerosis and lead to targeted successful treatments. On this page, we explain how our biomarkers for systemic sclerosis can provide such crucial value.

More about our biomarkers for Systemic Sclerosis

Please don't hesitate to contact us if you have any questions or other inquiries.

Are you interested in learning more about Nordic Bioscience?
Enter your information in the form and a representative will contact you shortly.

By submitting this form you agree to our terms and conditions.